NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.

Author(s): Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L, Symmans WF

Publication: J Natl Cancer Inst, 2011, Vol. 103, Page 1871-83

PubMed ID: 22034635 PubMed Review Paper? No

Purpose of Paper

This paper investigated the effects of cold ischemia (a room temperature delay prior to preservation) and preservation method (RNAlater versus snap freezing on dry ice) on the yield, integrity, and expression of RNA isolated from surgically resected breast tumors.

Conclusion of Paper

The method of preservation elicited a greater effect than the duration of cold ischemia on RNA yield, integrity, and expression analysis. With regard to preservation method, RNA integrity numbers (RIN) were significantly higher (8.13 versus 7.31), 3'/5' transcript ratios were lower, and RNA yield was 3-fold greater in RNAlater-preserved specimens compared to case-matched specimens that were snap frozen on dry ice. Estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2) mRNA levels, as determined by microarray, were modestly albeit significantly reduced in specimens preserved in RNAlater compared to those snap frozen on dry ice. A cold ischemia time (initiated after pathological evaluation) of 120 min produced modest but significant effects on RNA yield, integrity, the 3'/5' transcript ratio for several genes, and the genomic grade index (GGI).

Studies

  1. Study Purpose

    In order to assess the impact cold ischemia time and preservation method have on RNA yield, integrity, and expression, breast tumor specimens from 17 patients were minced, stirred, and divided into 8 equal portions that were then subjected to 0, 20, 40, 60, 120, or 180 min at room temperature if preserved by RNAlater or 0 or 40 min if preserved by snap-freezing on dry ice. Importantly, the cold ischemia time associated with pathological evaluation was recorded and ranged between 23 and 68 min, but was not included in the author-specified cold ischemia timepoints. All specimens were stored at -80 degrees C until analysis, and RNAlater-preserved specimens were held at room temperature for approximately 60 min prior to freezing.

    Summary of Findings:

    With regard to preservation method, RNAlater-preserved specimens had greater RNA yields (by 3-fold) and higher RIN (8.13 versus 7.31) compared to case-matched specimens snap frozen on dry ice. Of the 86 microarrays constructed from 11 patients, 5% failed microarray quality control tests although 8% had RIN values less than 6. Differences between preservation methods included a significantly lower 3'/5' ratio in RNAlater-preserved specimens compared to snap frozen specimens for beta-actin, gyceraldehyde 3-phosphate dehydrogenase (GAPDH), 18S rRNA (p<0.001) and signal transducer and activator of transcription 1 (STAT1; p=0.014), but lower average ER (p=0.003) and HER-2 (p=0.016) signals in RNAlater preserved specimens. When cold ischemia time was investigated, neither RNA yield nor RIN were affected by 40 min of cold ischemia compared to 0 min controls in snap frozen specimens. For RNAlater-preserved specimens, prolonged cold ischemia resulted in modest declines in RNA yield (1.5 ug/h; p=0.19) and RIN (0.12 unit/h; p=.008), while levels of single mRNA targets and multigene indices remained stable with the exception of a modest but significant decrease in GGI (p=0.007, -5.4 units/h). However, regression analysis revealed that 3'/5' ratios increased significantly for STAT1 (p=0.001), beta-actin (p=0.02), and 18S rRNA (p=0.006), and decreased for 28S rRNA (p=0.006) following prolonged cold ischemia in specimens preserved in RNAlater. RNA yield, but not RIN, was significantly affected by surgery type and tumor size (p=0.001). Warm ischemia time and the cold ischemia time associated with pathological evaluation did not significantly affect microarray results, although data was not shown.

    Biospecimens
    Preservative Types
    • RNAlater
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA Automated electrophoresis/Bioanalyzer
    RNA DNA microarray
    RNA Spectrophotometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation RNAlater
    Snap frozen
    Preaquisition Warm ischemia time 12-118 min
    Biospecimen Acquisition Cold ischemia time 0 min
    20 min
    40 min
    60 min
    120 min
    180 min
    DNA microarray Specific Targeted nucleic acid ER
    HER-2
    ACTB
    STAT1
    18S rRNA
    28S rRNA
    Biospecimen Acquisition Method of tissue acquisition Mastectomy
    Segmental mastectomy

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...